HealthFDA Clears SimBioSys Breast Cancer Recurrence Risk SoftwareBy Naomi CalderOct 15, 2026, 4:02 PM UTC
BusinessActinium Pharmaceuticals Appoints Dr. Jeffrey Chell, Bone Marrow Transplant Visionary and Chief Executive Officer Emeritus of Be The Match and National Marrow Donor Program, to its Board of DirectorsBy Nasdaq OMXMay 1, 2018, 11:31 AM UTC
BusinessEpilepsy Foundation Testifies Before FDA Advisory Committee in Support of Potential First-Ever Cannabidiol Drug to Treat Dravet SyndromeBy Nasdaq OMXApr 19, 2018, 4:07 PM UTC
BusinessAdamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with DyskinesiaBy Nasdaq OMXApr 19, 2018, 9:30 AM UTC
BusinessCancer Care Teams and Advocates Gather in Washington for Largest Community Oncology Conference EverBy Nasdaq OMXApr 12, 2018, 2:46 PM UTC
BusinessBioCorRx Provides Business Update for the Full Year Ended 2017By Nasdaq OMXApr 6, 2018, 11:30 AM UTC
